877397-68-7 Usage
Description
(1S)-1-(2,6-dichloro-3-fluorophenyl)ethyl acetate is a chemical compound with the molecular formula C10H10Cl2FO2. It is a derivative of acetic acid and belongs to the class of organic compounds known as fatty acid esters. (1S)-1-(2,6-dichloro-3-fluorophenyl)ethyl acetate is characterized by its two chlorine atoms, one fluorine atom, and a phenyl group attached to the ethyl acetate moiety.
Uses
Used in Pharmaceutical Synthesis:
(1S)-1-(2,6-dichloro-3-fluorophenyl)ethyl acetate is used as an intermediate in the synthesis of pharmaceuticals for its versatile properties and reactivity. It plays a crucial role in the development of new drugs and medicines.
Used in Agrochemical Production:
In the agrochemical industry, (1S)-1-(2,6-dichloro-3-fluorophenyl)ethyl acetate is used as a building block in the production of various agrochemicals. Its unique structure and reactivity make it suitable for creating effective and targeted pest control solutions.
Used as a Flavoring Agent:
Due to its aromatic nature, (1S)-1-(2,6-dichloro-3-fluorophenyl)ethyl acetate is used as a flavoring agent in the food and beverage industry. It imparts a distinct taste and aroma to various products, enhancing their overall sensory appeal.
Used as a Fragrance:
(1S)-1-(2,6-dichloro-3-fluorophenyl)ethyl acetate is also utilized as a fragrance in the cosmetics and perfumery industry. Its unique scent profile contributes to the creation of various fragrances and scents for a wide range of consumer products.
Check Digit Verification of cas no
The CAS Registry Mumber 877397-68-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,7,7,3,9 and 7 respectively; the second part has 2 digits, 6 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 877397-68:
(8*8)+(7*7)+(6*7)+(5*3)+(4*9)+(3*7)+(2*6)+(1*8)=247
247 % 10 = 7
So 877397-68-7 is a valid CAS Registry Number.
877397-68-7Relevant articles and documents
CRIZOTINIB FOR USE IN THE TREATMENT OF CANCER
-
, (2016/08/17)
The present invention relates to the use of ROS kinase inhibitors for treating abnormal cell growth in mammals. In particular, the invention provides methods of treating mammals suffering from cancer mediated by at least one genetically altered ROS. In particular, the invention provides methods of treating mammals suffering from cancer mediated by at least one genetically altered ROS by administration of crizotinib.
CRIZOTINIB FOR USE IN THE TREATMENT OF CANCER
-
, (2013/03/26)
The present invention relates to the use of ROS kinase inhibitors for treating abnormal cell growth in mammals. In particular, the invention provides methods of treating mammals suffering from cancer mediated by at least one genetically altered ROS. In particular, the invention provides methods of treating mammals suffering from cancer mediated by at least one genetically altered ROS by administration of crizotinib.
Polymorphs of a C-Met/Hgfr Inhibitor
-
Page/Page column 4, (2009/01/20)
This invention relates to polymorphs of (R)-3-[1-(2,6-Dichloro-3-fluoro-phenyl)-ethoxy]-5-(1-piperidin-4-yl-1H-pyrazol-4-yl)-pyridin-2-ylamine that are useful in the treatment of abnormal cell growth, such as cancer, in mammals. This invention also relates to compositions including such salts and polymorphs, and to methods of using such compositions in the treatment of abnormal cell growth in mammals, especially humans.
